Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PACB compared with BEAM: revenue, margins and what each company keeps, and the suppliers and customers both name
PACB
Pacific Biosciences of California, Inc.
Change
Mkt cap
Revenue
Revenue
BEAM
Beam Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PACB
Pacific Biosciences of California, Inc.
vs
BEAM
Beam Therapeutics Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
PACB
Pacific Biosciences of California, Inc.
Change
2.62
▼
−9.81%
· post 2.60
Mkt cap
$809.7M
Revenue
$39M
Q2 FY26
Revenue
$160M
FY25
BEAM
Beam Therapeutics Inc.
Change
27.24
▼
−5.55%
· post 27.04
Closed
Oct 30 '26
Mkt cap
$2.8B
Revenue
$490,000
Q2 FY26
Revenue
$140M
FY25
vs
Compare
Closed
Oct 30 '26
PACB
Pacific Biosciences of California, Inc.
vs
BEAM
Beam Therapeutics Inc.
2.62
▼
−9.81%
post 2.60
Price
27.24
▼
−5.55%
post 27.04
$809.7M
Mkt cap
$2.8B
Q2 FY26
$39M
Revenue
$490,000
Q2 FY26
FY25
$160M
Revenue
$140M
FY25
Change
Change
PACB
2.62
▼
−9.81%
vs
BEAM
27.24
▼
−5.55%
Closed
Oct 30 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PACB, solid
BEAM, dashed
Supply-chain overlap
Revenue flow
PACB: latest quarter is a loss; flow not drawable. BEAM: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only PACB
2
—
Illumina Cambridge
unlisted
supplier
—
Buyer
unlisted
customer
Shared
0
No shared counterparties.
Only BEAM
9
LLY
Eli Lilly
customer
PFE
Pfizer
customer
SANA
Sana Biotechnology
customer
PRME
Prime Medicine
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
5 more · BEAM chain
›